Characterization of recombinant tetanus toxin derivatives suitable for vaccine development

D. Figueiredo, C. Turcotte, G. Frankel, Y. Li, O. Dolly, G. Wilkin, D. Marriott, N. Fairweather, G. Dougan

Research output: Contribution to journalComment / DebateOtherpeer-review

34 Citations (Scopus)

Abstract

Recombinant derivatives of tetanus toxin (TeTx) were isolated and used to immunize mice. Recombinant TeTx light chain, a derivative of fragment C that had lost the ability to bind neurons, and a recombinant TeTx holotoxoid that could protect mice against TeTx challenge were identified.

Original languageEnglish
Pages (from-to)3218-3221
Number of pages4
JournalInfection and Immunity
Volume63
Issue number8
Publication statusPublished - 1 Jan 1995
Externally publishedYes

Cite this